Joanne (00:00):
With the passage of the Inflation Reduction Act of 2022, Medicare just received one of its biggest changes in years. So in today's episode, we will talk about what changes have been created by this bill, as well as when those changes will go into effect.
Cameron (00:13):
But before we start, my name is Cameron Giardini, and together with my co-host Joanne Giardini Russell, we operate Giardini Medicare, which is an independent insurance agency based out of Southeast Michigan. Although we are based in Michigan, we work virtually over the phone to directly help consumers in about 13 states to find the right Medicare coverage for them. If we do not work in your state, we will connect you with another trusted independent agent that will be able to help you find the coverage you want. Even if you choose not to work with us, we know that the information in this podcast will help you have a successful and stress-free transition to Medicare. So before we talk about change number one, just know that we also have a video on this topic. If you want to go to YouTube, you can search Giardini Medicare if you want to see the visuals that go along with this.
Cameron (01:02):
So with that out of the way, the first change being implemented by the Inflation Reduction Act is beginning in 2024, the out-of-pocket cost for individuals that reach catastrophic coverage of Part D will be reduced from 5% down to $0 for the rest of the year. Just keep in mind, catastrophic coverage is the final phase of Part D prescription coverage. And along with that, an even bigger change will begin in 2025, as there will be a $2,000 annual out-of-pocket cap on Part D and Medicare Advantage prescription drug coverage. This will include all of the out-of-pocket costs that you pay for covered medications like deductibles, co-insurance, and co-pays. However, this does not include your prescription drug plan monthly premiums that you pay directly to the private insurance company providing your coverage. And then lastly, with this change in 2025, beneficiaries will have the option of paying their out-of-pocket prescription cost and more affordable monthly payments. So instead of having to pay $2,000 upfront, if you have very expensive medications, you can spread that out and make it a little bit easier financially throughout the year. And then speaking of caps, I'll have Joanne talk about the next cap on different prescriptions.
Joanne (02:19):
Yes, this is actually great news. So there is a new $35 cap on insulin. So, beginning in 2023, Medicare-covered insulin will be capped at $35 for a one-month supply. Now, currently, there is a program called the Senior Savings Model, which does cap certain insulins with certain plans at $35 as well for a one-month supply. But this new bill should only expand that lower-cost insulin coverage to all Medicare beneficiaries that need it. So that's all insulins.
Cameron (02:47):
Yeah, and we're going to just keep going along the lines of caps on prescriptions here. So this is another big one that is starting in 2023. There will be no out-of-pocket costs for Part D-covered vaccines that are recommended by the Centers for Disease Control and Prevention, which is CDC. We'll link to that in the show notes so you can see which vaccines are included in this. But now the biggest one in our mind is the shingles vaccine. According to the Kaiser Family Foundation in 2020 alone, there were 4.1 million Medicare beneficiaries that received a Part D covered vaccine with 3.6 Million of those actually being the shingles vaccine. The reason this is so important is that many of our clients and future Medicare enrollees are shocked to learn that when they go to get a shingles vaccine, even with Medicare Part D, it's still at least a few hundred dollars out of pocket when you get both of the rounds of the medication. So this is something that it might not be huge for everybody, but at least for us and a lot of our clients, it'll be a huge help.
Joanne (03:50):
It's huge
Cameron (03:51):
<laugh>. Yeah, it’s big.
Joanne (03:52):
I love it. I do love it. So let's talk about the next change, which is the Part D premiums are going to be capped at a 6% increase cap. Beginning in 2024 and continuing through at least 2029, there will be a cap of 6% for yearly Part D premium increases. Now those are the plan premiums. The $2,000 cap on prescription costs that we discussed earlier does not apply to the monthly plan premium. So hopefully this will help keep all of those in check as well. Now, remember, part D plans are plans that you purchase from private insurance companies that contract with Medicare to provide you with prescription drug coverage.
Cameron (04:29):
Yeah. A lot of caps as you can see in this bill for different things when it comes to Medicare and then going away from that, one of the major things you'll probably see in headlines, or you've probably already seen is the fact that Medicare will finally be able to negotiate the cost of prescription prices. And this is not going to be every prescription, but we'll talk about that soon. So when Medicare Part D was first implemented or first created in 2003, it included a specific provision called the noninterference clause that made it so Medicare explicitly could not negotiate the price of prescription medications. So that's what makes this part of the bill a pretty big deal. This will be changing again with the implementation of the Inflation Reduction Act and starting in 2026, Medicare will negotiate the price for 10 of the most expensive Part D prescription drugs. Then in 2027, Medicare will negotiate the price for an additional 15 expensive Part D drugs in 2028, they will negotiate the price for an additional 15 Part B and Part D prescriptions. So now we're adding part B to the list. And then finally in 2029, Medicare will be able to negotiate the price for an additional 20 Part B and Part D prescriptions. So all said and done in 2029, these are all adding together. By that year there will be a total of 60 part D and part B medications being negotiated by Medicare.
Joanne (05:57):
Now, these are changes that are going to affect the low-income subsidy qualification. The low-income subsidy, which is also known as extra help, is a federal program that is designed to help Medicare beneficiaries save on their prescription drug costs, including the plan premiums and their out-of-pocket costs beginning in 2024. The income qualification level for the full extra help will be increasing from 135% of the federal poverty limit and going up to 150% of the federal poverty limit. So this means those with slightly higher incomes may still be able to qualify for a full low-income subsidy. And according to Social Security, full extra help if you qualify for that program is worth around $5,000 per year to consumers.
Cameron (06:41):
Yeah, and last but not least, we'll talk about the seventh major change that is happening with this bill and that is that prescription prices will be capped by inflation. So, beginning in 2023, drug manufacturers will have to pay rebates for part D and or part B medications if their prices increase faster than inflation, these rebates would be paid directly to Medicare in this situation. So of course inflation is a hot topic recently when it comes to all goods and services, but it is not new to prescription drugs because according to the Medicare Payment Advisory Commission, the price of brand-name Part D medications without generic alternatives has increased on average 7.5% per year over recent years way in advance of the recent inflation that we've seen all over the news. We'll go over a brief timeline of all these changes to wrap things up with the inflation reduction Act of 2022. In 2023, part B and part D manufacturers will have to pay rebates to Medicare if their medication prices increase faster than inflation.
Cameron (07:46):
There will also be no out-of-pocket cost for Part D-covered vaccines that are recommended by the CDC. Also covered Part D and Part B insulins will be capped at no more than $35 for a one-month supply. Next going into 2024, part D prescription cost for those that reach the catastrophic coverage phase will decrease from 5% out of pocket for the year all the way down to $0 for the remainder of the year. Also, in 2024, full low-income subsidy income qualifications will increase from 135% of the federal poverty limit up to 150%. And then lastly, in 2024, premiums for Part D prescription coverage will be limited to no more than a 6% yearly increase. Then moving on to 2025, there will be a $2,000 annual cap placed on Part D out-of-pocket costs. This will include the ability for beneficiaries to also pay for these costs in more affordable, broken-down monthly payments. So with that being said, I'll flip it over to Joanne to finish things off with the rest of the years.
Joanne (08:55):
Sounds good. So 2026, the government will begin negotiating the prices for 10 Part D prescription drugs. In 2027, the government will begin negotiating the prices for 15 additional Part D prescription drugs. In 2028, the government will begin negotiating the prices for 15 additional Part D and then also part B prescription drugs. And then finally in 2029, the government will begin negotiating the prices for 20 additional part D and part B prescription drugs. So it is going to have some impact. You can see it'll take a little bit of time, but at least these are major changes that are finally coming through the pipeline.
Cameron (09:31):
Yeah, there are a lot of changes coming. Overall, we hope these changes to Medicare from this new bill will help our clients as well as all Medicare-eligible beneficiaries. Of course, only time is going to tell, but we will continue to update you as we learn more details. So as always, please leave us a review on your podcast app and subscribe so you can listen to future episodes. You can also find more Medicare content from us by going to YouTube and searching Giardini Medicare. If you want to schedule a one-on-one phone call with one of our licensed brokers, you can schedule online at gmedicareteam.com or you can call us at (248) 871-7756. Last but not least, if you want to send us any feedback or questions, you can send us an email at info@gmedicareteam.com. So thank you very much for listening and have a wonderful day.